NCT02363868View on ClinicalTrials.gov

Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Chronic Myeloid Leukemia (CML)
Trial Locations (1)

29325

Franklin Pharmaceutical Consulting, Llc, Clinton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY